TWFG:NASDAQTWFG, Inc. Analysis
Data as of 2026-05-06 - not real-time
$18.92
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
TWFG is trading at $18.92, far below its DCF‑derived fair value of roughly $100, implying a potential upside of over 35%. The stock sits just above its technical support at $17.73 and below the 20‑day SMA (19.06), with a bearish MACD and a 30‑day volatility of 43%, suggesting short‑term price pressure. Despite a low beta of 0.12, the decreasing volume trend adds liquidity concerns. Fundamentally, the company posted $248.5 M in revenue with a 35.8% growth rate and an impressive 84.9% gross margin, though net profit margin is modest at 3.2% and free cash flow is negative. The balance sheet is modestly leveraged (debt‑to‑equity 4.9) and cash on hand exceeds debt. Analyst consensus remains a “Buy” with a mean target price of $25.7, reinforcing the valuation gap. The combination of strong top‑line growth, high margins, and a substantial undervaluation supports a bullish outlook beyond the immediate technical weakness.
Given the extreme greed sentiment in the market (Fear & Greed Index 90.38) and the stock’s low market cap, investors should weigh the upside potential against the near‑term bearish technicals and cash‑flow constraints. A medium‑ to long‑term position appears attractive, while short‑term exposure warrants caution.
Given the extreme greed sentiment in the market (Fear & Greed Index 90.38) and the stock’s low market cap, investors should weigh the upside potential against the near‑term bearish technicals and cash‑flow constraints. A medium‑ to long‑term position appears attractive, while short‑term exposure warrants caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Bearish MACD and price below short‑term SMA
- Proximity to technical support at $17.73
- Decreasing volume and negative free cash flow
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth of 35.8% and high gross margin
- DCF fair value indicating >35% upside
- Analyst consensus “Buy” with $25.7 mean target
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Substantial valuation gap to DCF estimate
- Low beta and stable US‑centric insurance brokerage model
- Potential for margin expansion and earnings growth
Key Metrics & Analysis
Financial Health
Revenue Growth35.80%
Profit Margin3.20%
P/E Ratio35.7
ROE13.91%
ROA6.64%
Debt/Equity4.89
P/B Ratio3.4
Op. Cash Flow$53.5M
Free Cash Flow$-35808752
Industry P/E16.6
Technical Analysis
TrendBearish
RSI47.9
Support$17.73
Resistance$20.56
MA 20$19.06
MA 50$19.12
MA 200$24.71
MACDBearish
VolumeDecreasing
Fear & Greed Index90.38
Valuation
Fair Value$99.93
Target Price$25.71
Upside/Downside35.91%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.12
Volatility43.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.